Oxford-based clinical AI company, Sensyne Health, has announced it has signed a production contract with the Department of Health & Social Care (DHSC) to use its MagnifEye system to read COVID-19 lateral flow diagnostic tests as part of the UK Government's asymptomatic testing programme.

Read the full article on TechMarketView here.